How Peptides Are Made: Solid-Phase Peptide Synthesis Explained

How research peptides are actually made

Almost every research peptide on the market is built by one method: solid-phase peptide synthesis (SPPS). Understanding how SPPS works is genuinely useful for a research buyer, because the method explains where impurities come from — and therefore why the analytics on a Certificate of Analysis look the way they do. This article walks through SPPS at a practical level and connects it to the quality checks that matter.

Everything here is background on research materials. The peptides Solis supplies are for laboratory research use only — not for human or veterinary use, and nothing below is medical, dosing, or usage guidance. For the basics of what peptides are, see our primer.

The core idea: building on a solid support

SPPS, developed by Robert Bruce Merrifield (work that earned a Nobel Prize), assembles a peptide one amino acid at a time on an insoluble resin bead. The growing chain stays anchored to the bead throughout, which lets the chemist wash away excess reagents and by-products at every step simply by filtering — the key convenience that made peptide synthesis scalable.

The chain is built from the C-terminus to the N-terminus, the opposite direction to how the body’s ribosomes build proteins.

The coupling cycle

Each amino acid is added by repeating a cycle:

  • Deprotection. The temporary protecting group on the end of the growing chain is removed to expose a reactive site.
  • Coupling. The next amino acid — itself protected on its side chain and activated at its reactive end — is coupled to the chain.
  • Washing. Excess reagents and by-products are washed away while the peptide stays bound to the resin.

This cycle repeats once per residue. A 30-amino-acid peptide means roughly 30 rounds — and this is exactly why longer peptides are harder to make cleanly, a point we return to below.

Cleavage and the origin of impurities

When the sequence is complete, the peptide is cleaved from the resin and its side-chain protecting groups are removed, then it is purified (typically by preparative HPLC) and freeze-dried into the lyophilised powder buyers receive.

The important insight for a buyer is where impurities come from. At each coupling step, a small fraction of chains may fail to react, producing deletion sequences (missing a residue) or truncated sequences. The more residues, the more chances for these errors to accumulate. This is why:

  • Longer, more complex peptides are generally harder to synthesise to high purity than short ones.
  • HPLC purity and mass spectrometry on the final lot are the tools that reveal whether these synthesis by-products were adequately removed.

Understanding SPPS turns a purity percentage from an abstract number into something concrete: it is a measure of how well the synthesis and purification handled these inevitable side-products.

Why this matters when comparing suppliers

Two vials labelled the same peptide can come from very different synthesis and purification quality. The label tells you the intended molecule; only the analytics tell you what the SPPS process actually produced. That is why serious research sourcing focuses on the lot-specific data — HPLC purity with a chromatogram and mass-spec identity — rather than the name on the vial.

Frequently asked questions

What is solid-phase peptide synthesis?

SPPS is the standard method for making peptides, assembling the chain one amino acid at a time on an insoluble resin bead, from the C-terminus to the N-terminus, before cleaving and purifying the finished peptide.

Why are longer peptides harder to make?

Each amino acid is added in a separate coupling step, and each step can leave a small fraction of failed chains. More residues means more steps and more opportunity for deletion or truncation by-products to accumulate.

How does synthesis relate to purity?

Impurities in a peptide lot are largely synthesis by-products — deletion and truncated sequences. HPLC purity and mass spectrometry on the final lot measure how well those were removed.

Does the synthesis method appear on a CoA?

The method is usually implied rather than detailed, but its consequences show up directly in the HPLC and mass-spec data, which is what a buyer should read.

In summary

Solid-phase peptide synthesis builds peptides one residue at a time on a resin, and its step-by-step nature is exactly why synthesis by-products arise and why longer peptides are harder to make cleanly. That is the practical reason a lot’s HPLC purity and mass-spec identity matter more than the name on the label. See how Solis documents its analytics on the Quality & Analytics page, or browse the catalogue.


Solis Peptides supplies research peptides for laboratory research use only — not for human or veterinary use, and not a medicine, supplement, or cosmetic. Nothing in this article is medical, dosing, or usage advice.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *